Coronary interventions Acute and long-term relocation of minimal lumen area after bioresorbable scaffold or metallic stent implantation Katagiri Y, Serruys P, Tenekecioglu E, Asano T, Collet C, Miyazaki Y, Katsikis A, Piek J, Wykrzykowska J, Chevalier B, Mintz G, Stone G, Onuma Y September 20, 2019 | 10.4244/EIJ-D-18-00422
Coronary interventions Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P August 9, 2019 | 10.4244/EIJ-D-19-00184
Coronary interventions A prospective multicentre randomised all-comers trial to assess the safety and effectiveness of the thin-strut sirolimus-eluting coronary stent SUPRAFLEX: rationale and design of the Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent (TALENT) trial Modolo R, Chichareon P, Kogame N, Asano T, Chang C, de Winter R, Kaul U, Zaman A, Spitzer E, Takahashi K, Katagiri Y, Soliman O, Van Es G-A, Morel M-A, Onuma Y, Serruys P July 19, 2019 | 10.4244/EIJ-D-18-00499
Coronary interventions Early strut protrusion and late neointima thickness in the Absorb bioresorbable scaffold: a serial wall shear stress analysis up to five years Tenekecioglu E, Torii R, Katagiri Y, Asano T, Modolo R, Miyazaki Y, Chichareon P, Poon E, Gijsen F, Thondapu V, van Klaveren D, Jonker H, Ooi A, Barlis P, Collet C, Onuma Y, Bourantas C, Serruys P July 19, 2019 | 10.4244/EIJ-D-18-00381
Coronary interventions On-line three-dimensional OFDI guided PCI vs. angiography guided in bifurcation lesions: design and rationale of the randomized OPTIMUM trial Miyazaki Y, Muramatsu T, Asano T, Katagiri Y, Sotomi Y, Nakatani S, Takahashi K, Kogame N, Higuchi Y, Ishikawa M, Kyono H, Yano M, Ozaki Y, Serruys P, Okamura T, Onuma Y July 9, 2019 | 10.4244/EIJ-D-18-00902
Coronary interventions Preclinical evaluation of a thin-strut bioresorbable scaffold (ArterioSorb): acute-phase invasive imaging assessment and hemodynamic implication. Katagiri Y, Torii R, Takahashi K, Tenekecioglu E, Asano T, Chichareon P, Tomaniak M, Piek J, Wykrzykowska J, Bullett N, Ahmed N, Al-Lamee K, Leclerc G, Kitslaar P, Dijkstra J, Reiber J, Poon E, Bourantas C, Gijsen F, Serruys P, Onuma Y July 9, 2019 | 10.4244/EIJ-D-18-01190
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study Serruys P, Farooq V, Banning A, Escaned J, Wykrzykowska J, Piek J, Dudek D, Ochala A, Hildick-Smith D, Goicolea J, Íñiguez-Romo A, Buszman P, Modolo R, Katagiri Y, Kogame N, Onuma Y June 12, 2019 | 10.4244/EIJ-D-18-00980
Coronary interventions How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials Katagiri Y, Serruys P, Asano T, Miyazaki Y, Chichareon P, Modolo R, Takahashi K, Kogame N, Wykrzykowska J, Piek J, Onuma Y May 20, 2019 | 10.4244/EIJ-D-18-00607
Coronary interventions Serial comparison of neointimal hyperplasia between the thin strut MiStent with microcrystalline sirolimus and the durable polymer coated everolimus-eluting Xience stent: 6- and 24-month results of DESSOLVE III OCT sub-study Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P May 7, 2019 | 10.4244/EIJ-D-18-01201
Coronary interventions Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs Onuma Y, Katagiri Y, Burzotta F, Holm N.R., Amabile N, Okamura T, Mintz G, Darremont O, Flensted Lassen J, Lefèvre T, Louvard Y, Stankovic G, Serruys P February 7, 2019 | 10.4244/EIJ-D-18-00391
Coronary interventions Two-year follow-up of the DESSOLVE III trial: bioabsorbable polymer sirolimus-eluting stent vs. durable polymer everolimus-eluting stent. Katagiri Y, Onuma Y, Lurz P, Buszman P, Piek J, Wykrzykowska J, Asano T, Kogame N, Takahashi K, Chang C, de Winter R, Serruys P, Wijns W February 5, 2019 | 10.4244/EIJ-D-18-00944
Coronary interventions Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents. A pooled analysis of individual patient data from 2 randomized trials Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iniguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P February 5, 2019 | 10.4244/EIJ-D-18-01080
Coronary interventions A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial Asano T, Jin Q, Katagiri Y, Kogame N, Takahashi K, Chang C, Chichareon P, Wang C, Shi B, Su X, Fu G, Wu Y, Zhou X, Yuan Z, Wykrzykowska J, Piek J, Serruys P, Onuma Y, Chen Y December 20, 2018 | 10.4244/EIJ-D-18-00461
Coronary interventions Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial) Katagiri Y, Onuma Y, Asano T, Iniguez A, Okkels Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P December 7, 2018 | 10.4244/EIJ-D-18-00839
Coronary interventions Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II) Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek J, Wykrzykowska J, Abizaid A, Ormiston J, Chevalier B, Serruys P October 12, 2018 | 10.4244/EIJ-D-18-00301
STEMI Quality difference of neointima following the implantation of everolimus-eluting bioresorbable scaffolds and metallic stents in patients with ST-elevation myocardial infarction: quantitative assessments by light intensity, light attenuation, and backscatter on optical coherence tomography in the TROFI II trial Sotomi Y, Onuma Y, Liu S, Asano T, Eggermont J, Katagiri Y, Cavalcante R, de Winter R, Wykrzykowska J, Brugaletta S, Räber L, Sabaté M, Windecker S, Dijkstra J, Serruys P August 24, 2018 | 10.4244/EIJ-D-17-00884
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolin R, van de Harst P, Iniguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabaté M, Onuma Y, Serruys P August 3, 2018 | 10.4244/EIJ-D-17-00461
Coronary interventions Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial Tijssen RY, Kraak R, Elias J, van Dongen I, Kalkman D, Nassif M, Sotomi Y, Asano T, Katagiri Y, Collet C, Piek J, Henriques J, de Winter R, Tijssen J, Onuma Y, Serruys P, Wykrzykowska J July 20, 2018 | 10.4244/EIJ-D-17-01152
Coronary interventions Interventional cardiology: review of the year 2017 Modolo R, Miyazaki Y, Chichareon P, Asano T, Collet C, Tenekecioglu E, Katagiri Y, Soliman O, Garg S, Onuma Y, Serruys P April 20, 2018 | 10.4244/EIJ-D-18-00066
A novel synchronised diastolic injection method to reduce contrast volume during aortography for aortic regurgitation assessment: in vitro experiment of a transcatheter heart valve model Miyazaki Y, Abdelghani M, de Boer E, Aben J-P, van Sloun M, Suchecki T, van ‘t Veer M, Collet C, Asano T, Katagiri Y, Tenekecioglu E, Soliman O, Onuma Y, de Winter R, Tonino P, van de Vosse F, Rutten M, Serruys P December 20, 2017 | 10.4244/EIJ-D-17-00355
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019